Prothena – $155 Million Shelf-Takedown Offering

San Francisco – March 23, 2017 – Cooley advised the underwriter on Prothena’s $155.3 million shelf-takedown offering of 2,700,000 ordinary shares. The underwriter has a 30-day option to purchase 405,000 additional ordinary shares.

Cantor Fitzgerald & Co. was the sole underwriter for the offering.

Prothena, which trades on The NASDAQ Global Select Market as “PRTA,” is a global, late-stage clinical biotechnology company with a clinical pipeline of novel therapeutic antibodies. Prothena is establishing a fully integrated research, development and commercial focus and has advanced several drug candidates into clinical studies while pursuing discovery of additional novel therapies.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Mark Weeks Partner, Palo Alto
John McKenna Partner, Palo Alto
David Ambler Associate, Palo Alto
Ryan James Associate, Palo Alto
Carol Laherty Partner, Seattle
Natasha Leskovsek Partner, Washington, DC
Phil Mitchell Partner, New York
Aaron Pomeroy Partner, Colorado
Francis Wheeler Partner, Colorado